Skip to content
Disclosery

ORACLE INVESTMENT MANAGEMENT INC

Follow

13F filer, CIK 1012622, GREENWICH, CT

ORACLE INVESTMENT MANAGEMENT INC reported $166,870,674 across 22 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-14. Its ten largest share positions make up 97.68% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001085146-24-005974

Period
2024-09-30
Reported value
$167M
Holdings
22
Top 10 weight
97.68%
New
4
Sold out
4

Largest buys vs the previous quarter

SecurityShares changeApprox. value
PHATadded+524,487$9.48M
MYGNadded+74,500$2.04M
PLTRnew+27,500$1.02M
PACBadded+304,739$518K
BHVNadded+4,800$240K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
SPRINGWORKS THERAPEUTICS INCreduced-199,000-$6.38M
WGSreduced-60,000-$2.55M
EYPTreduced-199,357-$1.59M
ARDXreduced-118,931-$819K
WALGREENS BOOTS ALLIANCE INCexited-27,500-$333K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2024

Share positions as resolved from 13F-HR 0001085146-24-005974, largest first. % of portfolio is the value over $125,124,163, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
WGSGENEDX HOLDINGS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 1,126,607 shares; 2024Q2: 1,105,768 shares; 2024Q3: 1,045,768 shares 1,045,768$44.4M35.47%-60,000Timeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 804,850 shares; 2024Q2: 700,450 shares; 2024Q3: 705,250 shares 705,250$35.2M28.17%+4,800Timeline
PHATPHATHOM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: not reported; 2024Q2: 225,000 shares; 2024Q3: 749,487 shares 749,487$13.6M10.83%+524,487Timeline
ARDXARDELYX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 2,039,700 shares; 2024Q2: 1,488,131 shares; 2024Q3: 1,369,200 shares 1,369,200$9.43M7.54%-118,931Timeline
QDELQUIDELORTHO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 157,201 shares; 2024Q2: 118,291 shares; 2024Q3: 118,291 shares 118,291$5.39M4.31%0Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 535,558 shares; 2024Q2: 535,558 shares; 2024Q3: 535,558 shares 535,558$4.07M3.25%0Timeline
MYGNMYRIAD GENETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: not reported; 2024Q2: 60,000 shares; 2024Q3: 134,500 shares 134,500$3.68M2.94%+74,500Timeline
FORAFORIAN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 1,355,807 shares; 2024Q2: 1,356,107 shares; 2024Q3: 1,356,107 shares 1,356,107$2.93M2.34%0Timeline
CAVACAVA GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 17,600 shares; 2024Q2: 18,600 shares; 2024Q3: 18,600 shares 18,600$2.3M1.84%0Timeline
PACBPACIFIC BIOSCIENCES CALIF INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 1,356,026 shares; 2024Q2: 423,138 shares; 2024Q3: 727,877 shares 727,877$1.24M0.99%+304,739Timeline
SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 421,583 shares; 2024Q2: 233,200 shares; 2024Q3: 34,200 shares 34,200$1.1M0.88%-199,000
PLTRPALANTIR TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 27,500 shares 27,500$1.02M0.82%newTimeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 2,412 shares; 2024Q2: 2,412 shares; 2024Q3: 2,412 shares 2,412$468K0.37%0Timeline
EYPTEYEPOINT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 461,857 shares; 2024Q2: 231,857 shares; 2024Q3: 32,500 shares 32,500$260K0.21%-199,357Timeline
BIODESIX INCBIODESIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 30,351 shares; 2024Q2: 28,916 shares; 2024Q3: 28,916 shares 28,916$51.5K0.04%0

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
BIOHAVEN LTDBIOHAVEN LTD COMcall302,700$15.1M+187,700
SPDR SERIES TRUSTSPDR SERIES TRUST ST STR SP BIOTcall100,000$9.88Mnew
NOVAVAX INCNOVAVAX INC COM NEWcall534,600$6.75Mnew
PHATHOM PHARMACEUTICALS INCPHATHOM PHARMACEUTICALS INC COMcall192,700$3.48Mnew
ARDELYX INCARDELYX INC COMcall430,200$2.96M+170,600
EYEPOINT INCEYEPOINT INC CALLcall350,000$2.8M-88,100
PALANTIR TECHNOLOGIES INCPALANTIR TECHNOLOGIES INC CALLcall20,000$744K-50,000

Sold out in Q3 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
MYRIAD GENETICS INCMYRIAD GENETICS INC74,500$1.82Mcall
SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INC17,800$671Kcall
WALGREENS BOOTS ALLIANCE INCWALGREENS BOOTS ALLIANCE INC27,500$333Kshares
AGENAGENUS INC17,500$293Kshares

How Q3 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001085146-24-005974 base2024-11-14acceptance time not in the bulk data set